Apellis Pharmaceuticals Inc Institutional ownership
What is the Institutional ownership of Apellis Pharmaceuticals Inc?
The Institutional ownership of Apellis Pharmaceuticals Inc is 90.92%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Apellis Pharmaceuticals Inc
What does Apellis Pharmaceuticals Inc do?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Companies with institutional ownership similar to Apellis Pharmaceuticals Inc
- Sempra has Institutional ownership of 90.88%
- Cheniere has Institutional ownership of 90.89%
- Century Communities Inc has Institutional ownership of 90.89%
- Liberty Global Ltd has Institutional ownership of 90.89%
- Navistar International has Institutional ownership of 90.89%
- Capri Ltd has Institutional ownership of 90.89%
- Apellis Pharmaceuticals Inc has Institutional ownership of 90.92%
- Brady has Institutional ownership of 90.93%
- IDEAYA Biosciences has Institutional ownership of 90.93%
- Cracker Barrel Old Country Store Inc has Institutional ownership of 90.94%
- Terex has Institutional ownership of 90.94%
- Keros Therapeutics has Institutional ownership of 90.96%
- Darden Restaurants has Institutional ownership of 90.96%